as reported January 1, 2003
Get the latest industry news, event updates, and more from Managed healthcare Executive.
FDA Approves Eydenzelt, Additional Eylea Biosimilar
Read More
Repatha Now Available for Approximately 60% Off List Price
Novartis to Offer Cosentyx to Cash Paying Patients at a 55% Discount
Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes
FDA Approves Extended Indication for Evkeeza
AstraZeneca to Offer Airsupra Direct to Patient